1. Home
  2. FEIM vs OPTN Comparison

FEIM vs OPTN Comparison

Compare FEIM & OPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEIM
  • OPTN
  • Stock Information
  • Founded
  • FEIM 1961
  • OPTN 2010
  • Country
  • FEIM United States
  • OPTN United States
  • Employees
  • FEIM N/A
  • OPTN N/A
  • Industry
  • FEIM Electrical Products
  • OPTN Biotechnology: Pharmaceutical Preparations
  • Sector
  • FEIM Industrials
  • OPTN Health Care
  • Exchange
  • FEIM Nasdaq
  • OPTN Nasdaq
  • Market Cap
  • FEIM 129.3M
  • OPTN 78.4M
  • IPO Year
  • FEIM N/A
  • OPTN 2017
  • Fundamental
  • Price
  • FEIM $19.02
  • OPTN $0.42
  • Analyst Decision
  • FEIM
  • OPTN Strong Buy
  • Analyst Count
  • FEIM 0
  • OPTN 3
  • Target Price
  • FEIM N/A
  • OPTN $3.00
  • AVG Volume (30 Days)
  • FEIM 137.6K
  • OPTN 835.9K
  • Earning Date
  • FEIM 12-10-2024
  • OPTN 11-12-2024
  • Dividend Yield
  • FEIM 5.26%
  • OPTN N/A
  • EPS Growth
  • FEIM 183.83
  • OPTN N/A
  • EPS
  • FEIM 0.82
  • OPTN N/A
  • Revenue
  • FEIM $60,188,000.00
  • OPTN $75,672,000.00
  • Revenue This Year
  • FEIM N/A
  • OPTN $13.42
  • Revenue Next Year
  • FEIM N/A
  • OPTN $52.99
  • P/E Ratio
  • FEIM $22.60
  • OPTN N/A
  • Revenue Growth
  • FEIM 21.33
  • OPTN 5.13
  • 52 Week Low
  • FEIM $8.62
  • OPTN $0.32
  • 52 Week High
  • FEIM $19.47
  • OPTN $2.10
  • Technical
  • Relative Strength Index (RSI)
  • FEIM 85.09
  • OPTN 35.42
  • Support Level
  • FEIM $13.61
  • OPTN $0.39
  • Resistance Level
  • FEIM $19.47
  • OPTN $0.57
  • Average True Range (ATR)
  • FEIM 0.94
  • OPTN 0.05
  • MACD
  • FEIM 0.47
  • OPTN -0.00
  • Stochastic Oscillator
  • FEIM 93.35
  • OPTN 16.53

About FEIM Frequency Electronics Inc.

Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.

About OPTN OptiNose Inc.

OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.

Share on Social Networks: